251 related articles for article (PubMed ID: 19349226)
1. Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo.
Pievani M; Rasser PE; Galluzzi S; Benussi L; Ghidoni R; Sabattoli F; Bonetti M; Binetti G; Thompson PM; Frisoni GB
Neuroimage; 2009 May; 45(4):1090-8. PubMed ID: 19349226
[TBL] [Abstract][Full Text] [Related]
2. APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease.
Pievani M; Galluzzi S; Thompson PM; Rasser PE; Bonetti M; Frisoni GB
Neuroimage; 2011 Apr; 55(3):909-19. PubMed ID: 21224004
[TBL] [Abstract][Full Text] [Related]
3. Association of sex and APOE ε4 with brain tau deposition and atrophy in older adults with Alzheimer's disease.
Yan S; Zheng C; Paranjpe MD; Li J; Benzinger TLS; Lu J; Zhou Y
Theranostics; 2020; 10(23):10563-10572. PubMed ID: 32929366
[TBL] [Abstract][Full Text] [Related]
4. Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.
Gutiérrez-Galve L; Lehmann M; Hobbs NZ; Clarkson MJ; Ridgway GR; Crutch S; Ourselin S; Schott JM; Fox NC; Barnes J
Dement Geriatr Cogn Disord; 2009; 28(5):476-85. PubMed ID: 19940480
[TBL] [Abstract][Full Text] [Related]
5. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
Liu Y; Paajanen T; Westman E; Wahlund LO; Simmons A; Tunnard C; Sobow T; Proitsi P; Powell J; Mecocci P; Tsolaki M; Vellas B; Muehlboeck S; Evans A; Spenger C; Lovestone S; Soininen H;
J Alzheimers Dis; 2010; 21(3):947-66. PubMed ID: 20693633
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
Wang X; Wang J; He Y; Li H; Yuan H; Evans A; Yu X; He Y; Wang H
J Alzheimers Dis; 2015; 45(3):781-95. PubMed ID: 25624419
[TBL] [Abstract][Full Text] [Related]
7. Regional atrophy of transcallosal prefrontal connections in cognitively normal APOE epsilon4 carriers.
Filippini N; Zarei M; Beckmann CF; Galluzzi S; Borsci G; Testa C; Bonetti M; Beltramello A; Ghidoni R; Benussi L; Binetti G; Frisoni GB
J Magn Reson Imaging; 2009 May; 29(5):1021-6. PubMed ID: 19388128
[TBL] [Abstract][Full Text] [Related]
8. Greater tau load and reduced cortical thickness in APOE ε4-negative Alzheimer's disease: a cohort study.
Mattsson N; Ossenkoppele R; Smith R; Strandberg O; Ohlsson T; Jögi J; Palmqvist S; Stomrud E; Hansson O
Alzheimers Res Ther; 2018 Aug; 10(1):77. PubMed ID: 30086796
[TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.
Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY
Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631
[TBL] [Abstract][Full Text] [Related]
10. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease.
Filippini N; Rao A; Wetten S; Gibson RA; Borrie M; Guzman D; Kertesz A; Loy-English I; Williams J; Nichols T; Whitcher B; Matthews PM
Neuroimage; 2009 Feb; 44(3):724-8. PubMed ID: 19013250
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.
Wolk DA; Dickerson BC;
Proc Natl Acad Sci U S A; 2010 Jun; 107(22):10256-61. PubMed ID: 20479234
[TBL] [Abstract][Full Text] [Related]
12. Selective brain gray matter atrophy associated with APOE ε4 and MAPT H1 in subjects with mild cognitive impairment.
Goñi J; Cervantes S; Arrondo G; Lamet I; Pastor P; Pastor MA
J Alzheimers Dis; 2013; 33(4):1009-19. PubMed ID: 23064258
[TBL] [Abstract][Full Text] [Related]
13. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
14. Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.
Alexander GE; Bergfield KL; Chen K; Reiman EM; Hanson KD; Lin L; Bandy D; Caselli RJ; Moeller JR
Neurobiol Aging; 2012 Dec; 33(12):2723-32. PubMed ID: 22405043
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia.
Agosta F; Vossel KA; Miller BL; Migliaccio R; Bonasera SJ; Filippi M; Boxer AL; Karydas A; Possin KL; Gorno-Tempini ML
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):2018-22. PubMed ID: 19164761
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in apolipoprotein E alters regional gray matter volumes in remitted late-onset depression.
Yuan Y; Zhang Z; Bai F; You J; Yu H; Shi Y; Liu W
J Affect Disord; 2010 Mar; 121(3):273-7. PubMed ID: 19647324
[TBL] [Abstract][Full Text] [Related]
17. APOE-epsilon4 and aging of medial temporal lobe gray matter in healthy adults older than 50 years.
Taylor JL; Scanlon BK; Farrell M; Hernandez B; Adamson MM; Ashford JW; Noda A; Murphy GM; Weiner MW
Neurobiol Aging; 2014 Nov; 35(11):2479-2485. PubMed ID: 24929969
[TBL] [Abstract][Full Text] [Related]
18. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
[TBL] [Abstract][Full Text] [Related]
19. Episodic memory of APOE ε4 carriers is correlated with fractional anisotropy, but not cortical thickness, in the medial temporal lobe.
Westlye ET; Hodneland E; Haász J; Espeseth T; Lundervold A; Lundervold AJ
Neuroimage; 2012 Oct; 63(1):507-16. PubMed ID: 22796460
[TBL] [Abstract][Full Text] [Related]
20. Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease.
Nemes S; Logan PE; Manchella MK; Mundada NS; La Joie R; Polsinelli AJ; Hammers DB; Koeppe RA; Foroud TM; Nudelman KN; Eloyan A; Iaccarino L; Dorsant-Ardón V; Taurone A; Thangarajah M; Dage JL; Aisen P; Grinberg LT; Jack CR; Kramer J; Kukull WA; Murray ME; Rumbaugh M; Soleimani-Meigooni DN; Toga A; Touroutoglou A; Vemuri P; Atri A; Day GS; Duara R; Graff-Radford NR; Honig LS; Jones DT; Masdeu J; Mendez MF; Musiek E; Onyike CU; Riddle M; Rogalski E; Salloway S; Sha SJ; Turner RS; Wingo TS; Womack KB; Wolk DA; Rabinovici GD; Carrillo MC; Dickerson BC; Apostolova LG;
Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S49-S63. PubMed ID: 37496307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
